Delivery Order SPE2DB24D1021-SPE2DB25FEXHL
Award Date
6/3/25
Potential Completion Date
6/4/25
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $3,385.86 Firm Fixed Price delivery order is for the supply of QSYMIA 3.75 MG-23 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of May 14, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of QSYMIA 3.75 MG-23 MG capsules, with a ceiling value of $4,145.22 and a completion date of September 11, 2024. This contract is not set-aside and is a firm fixed-price delivery order. Amerisourcebergen is a prominent supplier of pharmaceutical products and medical supplies to various federal...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4568520731 - QSYMIA 3.75 MG-23 MG CAPSULE 30S, a prescription medication. The total ceiling value of the contract is $1,587.98, with a firm fixed price pricing type. The contract has an ultimate completion date of June 12, 2025. This appears to be a non-set-aside...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of QSYMIA 7.5 MG-46 MG CAPSULE 30S, a prescription medication, with an ultimate completion date of June 10, 2025 and a ceiling value of $1,032.01. The contract is not set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,324.07 firm fixed-price delivery order is for the provision of QSYMIA 7.5 MG-46 MG CAPSULE 30S, with a performance period extending through May 27, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,296.52, is for the delivery of medical supplies and pharmaceuticals, including QSYMIA 15MG-92MG 30S, to support military healthcare programs. The contract has an ultimate completion date of April 8, 2025 and is not set aside for any specific business type....
This is a $3,656.97 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The order is for the supply of the drug QSYMIA 3.75 MG-23 MG Capsule, with a completion date of January 24, 2024. Amerisourcebergen Drug Corp has previously received numerous federal contract awards from DLA Troop Support Medical to provide...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,350.68, is for the delivery of Qsymia 3.75 mg-23 mg capsules in quantities of 30. The contract has a firm fixed price pricing type and an ultimate completion date of May 7, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
The U.S. government awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug QSYMIA 7.5MG-46MG 30S. The contract, valued at $1,663.14, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a unit of the Department of Defense (DoD). Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, worth up to $999,999,999.00 through December 2025, which serves as the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $748,537.50, is a Firm Fixed Price delivery order that will run through May 12, 2025. Amerisourcebergen Drug Corp will provide a variety of pharmaceutical products and medical supplies to support military healthcare programs, including medications across multiple therapeutic areas such as diabetes,...